The continued use of GLP-1 weight loss drugs could cut mortality rates by up to 6.4% by 2045, according to new research spearheaded by Swiss Re. Titled "The future of metabolic health and weight loss ...
STAMFORD, Conn.--(BUSINESS WIRE)--Gen Re announced the results of a broad study covering 208,428 person-years that determined that the PAI Health proprietary physical activity metric and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback